Hypertension Beijing 2018 welcomes abstract submissions from clinicians, scientists, academics and students.
Authors should choose one topic only for every abstract submitted. If an abstract fits into more than one of the topics below, choose the most appropriate one.
- Genetics, genomics, proteomics and metabolomics
- Sympathetic nervous system activation and neural and reflex mechanisms in hypertension
- Experimental pharmacology/Emerging therapeutics
- Experimental hypertension/Animal models of hypertension
- Inflammation/Immunity in hypertension
- Recent update in renin angiotensin system
- Arterial remodeling/Microcirculation/Endothelium
- Molecular biology/Receptors, channels and transporters
- Vascular biology
- How to manage hypertension in low resource settings
- Primary prevention strategy for dyslipidemia in hypertension
- Lifestyle modification in hypertension
- Epidemiology of hypertension
- IT technology in hypertension
- Cerebrovascular disease/Stroke
- Dementia and cognitive dysfunction
- Public health/Pharmacoeconomics
- Salt and hypertension
- Psychosocial stress and hypertension
- Community control
- Liquor spirits alcohol
- Elderly hypertension
- Secondary hypertension
- Hypertension in pregnancy/Women and hypertension
- Pediatric/Adolescent hypertension
- Hypertension in chronic kidney disease/Post renal transplantation
- Pharmacologic treatment of hypertension
- Traditional Chinese Medicine/Herb Medicine
- Cardiovascular risk assessment strategy in hypertension
- Hormone and Endocrinology
- Obesity/Metabolic syndrome and cardiovascular disease
- Central blood pressure/Large artery
- Target organ damage in hypertension
- Recent advances in non-pharmacologic treatment of device
- Recent advances in non-pharmacologic treatment of resistant Hypertension
- Renovascular in hypertension
- Sleep disorder/Obstructive sleep apnea
- Heart failure
- Blood pressure measurements: office and out of office
- Clinical trials
- Treatment adherence
- Atrial fibrillation
- Sports/Exercise and hypertension
- Imaging modalities
Abstract Submission Guidelines
- Abstracts can ONLY be submitted online via the congress website. Abstracts sent by post or email will not be accepted.
- For standardization, the acceptable length of the abstract is a maximum of 1,800 characters including non-visible characters, such as spaces and line breaks. This does not include the author’s details, titles, tables and figures.
- Each submitted abstract should be typed in English.
- When you submit an abstract online, it will be automatically edited according to the Hypertension Beijing 2018 submission format. It is the authors’ responsibility to review the submissions and correct them. Please proofread your abstract before completing your submission.
- Only one figure or one table each is allowed in an abstract.
- A confirmation of receipt of the abstract will be automatically sent to the correspondence author’s email upon their on-line submission.
- All abstracts that have been published in a full paper may not be submitted.
- Each registered account is limited to submit up to 3 abstracts.
- The presenting author will be default to the participant who registered the account and required to pay the registration.
- If authors wish to withdraw their abstracts from presentation or publication they are requested to send a letter via e-mail to email@example.com. withdrawn abstracts cannot be presented nor will these be published.
- The content of the abstract should briefly state:
Objectives (Indicate the purpose of the study).
Methods (Describe pertinent experimental procedures).
Results (Present as clearly as possible the outcome of the study).
Conclusion (Briefly discuss the data and emphasize the significance of the results).
ABSTRACT SUBMISSION Click above for submission
Deadline for abstract submission is 28 February 2018